Categories AlphaGraphs, Earnings, Health Care
ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided guidance for fiscal 2023.
Total revenues decreased 9.7% year-over-year to $12.23 billion, reflecting weakness in the main operating segments.
At $2.46 per share, adjusted net income was lower than the $3.16 per share reported in the prior-year period. First-quarter unadjusted profit dropped to $239 million or $0.13 per share from $4.49 billion or $2.51 per share in the first quarter of 2022.
“This year is off to an excellent start, with first-quarter revenues and EPS ahead of our expectations, driven by strong commercial execution across all areas of our diversified portfolio,” said Richard A. Gonzalez, CEO of AbbVie.
Prior Performance
Most Popular
Key highlights from Bank of America’s (BAC) Q4 2024 earnings results
Bank of America Corporation (NYSE: BAC) reported its fourth quarter 2024 earnings results today. Revenue, net of interest expense, was $25.3 billion, up 15% year-over-year. Net income was $6.7 billion,
US Bancorp (USB) Q4 profit rises on higher revenues, beats estimates
U.S. Bancorp (NYSE: USB) Thursday reported an increase in revenue and profit for the fourth quarter of 2024. Earnings also came in above analysts' forecasts. Total net revenue increased 3.7%
UnitedHealth Group (UNH) Q4 2024 Earnings: Key financials and quarterly highlights
UnitedHealth Group (NYSE: UNH) reported its fourth quarter 2024 earnings results today. Total revenues were $100.8 billion compared to $94.4 billion reported in the same period a year ago. Net